Sweden: Vitrolife raises Skr3.6bn to help finance acquisition of Igenomix

Gothenburg-based developer and manufacturer of products for assisted reproduction, Vitrolife, completed a directed share issue of around 9.6 million shares on July 8, raising approximately Skr3.6bn (US$120m) to help finance its acquisition of Spanish reproductive genetic testing services provider, Igenomix, from PE firms EQT and Charme Capital Partners for €1.25bn (US$1.48bn). Vitrolife is a biotechnology…

You must be a HMI Subscriber to view this content.

Subscribe Now »